Papers 1–10 of
12
by Michael B Black
- MB Black, A Stern, P Mallick, M Moreau, JK Hartman, PD McMullen, and AY Efremenko. Biological system considerations for application of toxicogenomics in next-generation risk assessment and predictive toxicology. Toxicol In Vitro 80 : 105311 (Apr 14, 2022). [abstract] [pubmed]
- MB Black, ME Andersen, SN Pendse, SJ Borghoff, M Streicker, and PD McMullen. RNA-sequencing (transcriptomic) data collected in liver and lung of male and female B6C3F1 mice exposed to various dose levels of 4-methylimidazole for 2, 5, or 28 days. Data Brief 38 : 107420 (Oct 23, 2021). [abstract] [pubmed]
- SJ Borghoff, SE Fitch, MB Black, PD McMullen, ME Andersen, and GA Chappell. A systematic approach to evaluate plausible modes of actions for mouse lung tumors in mice exposed to 4-methylimidozole. Regul Toxicol Pharmacol 124 : 104977 (Aug 24, 2021). [abstract] [pubmed]
- R Nault, B Bals, F Teymouri, MB Black, ME Andersen, PD McMullen, S Krishnan, N Kuravadi, N Paul, S Kumar, K Kannan, KC Jayachandra, L Alagappan, BD Patel, KT Bogen, BB Gollapudi, JE Klaunig, TR Zacharewski, and V Bringi. A toxicogenomic approach for the risk assessment of the food contaminant acetamide. Toxicol Appl Pharmacol 388 : 114872 (Feb 1, 2020). [abstract] [pubmed]
- PD McMullen, SN Pendse, MB Black, K Mansouri, S Haider, ME Andersen, and RA Clewell. Addressing systematic inconsistencies between in vitro and in vivo transcriptomic mode of action signatures. Toxicol In Vitro 58 : 1-12 (Aug 23, 2019). [abstract] [pubmed]
- PD McMullen, SN Pendse, MB Black, K Mansouri, S Haider, ME Andersen, and RA Clewell. Addressing systematic inconsistencies between in vitro and in vivo transcriptomic mode of action signatures. Toxicol In Vitro 58 : 1-12 (Aug 23, 2019). [abstract] [pubmed]
- BA Wetmore, RA Clewell, B Cholewa, B Parks, SN Pendse, MB Black, K Mansouri, S Haider, EL Berg, RS Judson, KA Houck, M Martin, HJ Clewell, ME Andersen, RS Thomas, and PD McMullen. Assessing bioactivity-exposure profiles of fruit and vegetable extracts in the BioMAP profiling system. Toxicol In Vitro 54 : 41-57 (Feb 12, 2019). [abstract] [pubmed]
- S Haider, MB Black, BB Parks, B Foley, BA Wetmore, ME Andersen, RA Clewell, K Mansouri, and PD McMullen. A Qualitative Modeling Approach for Whole Genome Prediction Using High-Throughput Toxicogenomics Data and Pathway-Based Validation. Front Pharmacol 9 : 1072 (Oct 2, 2018). [abstract] [pubmed]
- ME Andersen, G Cruzan, MB Black, SN Pendse, DE Dodd, JS Bus, SS Sarang, MI Banton, R Waites, DB Layko, and PD McMullen. Strain-related differences in mouse lung gene expression over a two-year period of inhalation exposure to styrene: Relevance to human risk assessment. Regul Toxicol Pharmacol 96 : 153-166 (Jul 17, 2018). [abstract] [pubmed]
- ME Andersen, G Cruzan, MB Black, SN Pendse, D Dodd, JS Bus, SS Sarang, MI Banton, R Waites, and PD McMullen. Assessing molecular initiating events (MIEs), key events (KEs) and modulating factors (MFs) for styrene responses in mouse lungs using whole genome gene expression profiling following 1-day and multi-week exposures. Toxicol Appl Pharmacol 335 : 28-40 (Nov 15, 2017). [abstract] [pubmed]